JonesTrading Initiates Coverage On IN8bio with Buy Rating, Announces Price Target of $5
Portfolio Pulse from Benzinga Newsdesk
JonesTrading analyst Soumit Roy initiates coverage on IN8bio (NASDAQ:INAB) with a Buy rating and sets a price target of $5.

March 13, 2024 | 8:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JonesTrading has initiated coverage on IN8bio with a Buy rating and a price target of $5.
The initiation of coverage by JonesTrading with a Buy rating and a price target of $5 is a strong positive signal for IN8bio. This endorsement from a reputable analyst could attract investor attention and potentially drive the stock price up in the short term, especially if the market perceives this new coverage as a credible endorsement of IN8bio's value and future prospects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100